Aerie Pharmaceuticals Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 0
Bid Price 15.24
Ask Price 14.79
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Aerie Pharmaceuticals Inc AERI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 15.25 19:00:00
Open Price Low Price High Price Close Price Prev Close
15.25 15.25
Trades Volume Avg Volume 52 Week Range
0 0 - 4.81 - 15.37
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 15.25 USD


Draw Mode:

Aerie Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 753.62M 49.42M 48.57M $ 194.13M $ -39.35M -1.62 -20.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.04k 3.10%

more financials information »

Aerie Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AERI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month15.2115.2515.2115.24521,1680.040.26%
3 Months15.1715.2615.0415.18786,5190.080.53%
6 Months4.9215.374.8113.391,115,42110.33209.96%
1 Year9.9515.374.8110.761,036,1095.3053.27%
3 Years19.2726.264.8113.45832,936-4.02-20.86%
5 Years65.7074.754.8121.75754,338-50.45-76.79%

Aerie Pharmaceuticals Description

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases, and retinal diseases. Its main products are Rhopressa and Roklatan. The company mainly operates in North America.